Pharmaceutical composition for diabetic nephropathy and its preparation and application
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 20, 2015
Grant Date -
Mar 1, 2012
app pub date -
Nov 2, 2011
filing date -
Jan 16, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to application of 4,4′-diphenylmethane-bis(methyl) carbamates (DPMC) extracted and isolated from Cortex Mori and preparation of medicine for diabetic nephropathy. The pharmaceutical composition is made up of DPMC as active ingredient and the normal drug carriers, and the weight percentage of active ingredient is 0.1-99.5%. For the remarkable effect of prevention and cure for diabetic nephropathy and convenience for use, it will be a new facultative drug for patients.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully